524790 — Everest Organics Share Price
0.000.00%
Last trade - 00:00- IN₹3.41bn
- IN₹3.92bn
- IN₹1.97bn
- 60
- 13
- 93
- 59
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 7.65 | ||
| Price to Tang. Book | 7.94 | ||
| Price to Free Cashflow | 55.3 | ||
| Price to Sales | 1.81 | ||
| EV to EBITDA | 53.47 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 0.85% | ||
| Return on Equity | -9.6% | ||
| Operating Margin | 0.29% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 1,672.12 | 1,815.67 | 2,000.47 | 1,830.48 | 1,972.41 | n/a | n/a | 4.82% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +45.12 | +25.86 | -91.66 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Everest Organics Limited is engaged in the business of manufacturing of active pharmaceutical ingredients (API) and intermediaries. It is involved in the manufacturing of bulk drugs. The Company’s API products include Omeprazole, Pantoprazole Sodium Sesquihydrate, Esomeprazole Magnesium Trihydrate, Esomeprazole Magnesium Dihydrate, Esomeprazole Sodium, Omeprazole Sodium, Omeprazole Magnesium, Fenofibrate, Tamsulosin Hcl, and Dexlansoprazole. Its products under development include Remdesivir, Molnupiravir, Carbidopa, Acotiamide HCL, and Apixaban. Its intermediates products include Ethyl 2-(4-Hydroxyphenyl)-4-Methyl-5-Thiazolecarboxylate, Ethyl 2-(3-Formyl-4-Hydroxyphenyl)-4-Methylthiazole-5- Carboxylate, Ethyl 2-(3-Formyl-4-Isobutoxyphenyl)-4-Methylthiazole-5-Carboxylate, Ethyl 2-(3-Cyano-4-Isobutoxyphenyl)-4-Methyl-5- Thiazolecarboxylate, 2-Chloromethyl-4-Methoxy-3-Methyl-Pyridine Hydrochloride, and 5-(1H-Pyroll-1-yl)-2-Mercaptobenzimidazole, among others.
Directors
- Srikakarlapudi Sirisha CEO
- Rekha Singh CCO
- Sri Raju MDR
- M. Bangara Raju EDR
- S.K.Hari Krishna EDR
- A. Parvatisem EDR
- G. Sreeramakrishna DRC
- Raju Kakarlapudi NED
- Venkatasatyanarayana Chayaly NID (56)
- Sreeramakrishna Grandhi NID
- K. Rama Raju NID
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- February 19th, 1993
- Public Since
- January 5th, 1995
- No. of Shareholders
- 10,026
- No. of Employees
- 423
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Bombay Stock Exchange
- Shares in Issue
- 9,710,526
- Address
- Plot No. 127.128, Kavuri Hills, Madhapur, HYDERABAD, 500033
- Web
- https://www.everestorganicsltd.com/
- Phone
- +91 4040040783
- Auditors
- P.S.N.Ravi Shanker & Associates
Upcoming Events for 524790
Q1 2026 Everest Organics Ltd Earnings Release
Similar to 524790
Aayush Wellness
Bombay Stock Exchange
Achyut Healthcare
Bombay Stock Exchange
Adline Chem Lab
Bombay Stock Exchange
MPS Pharmaa
Bombay Stock Exchange
Albert David
Bombay Stock Exchange
FAQ
What is the Everest Organics share price?
As of Today at 20:32 UTC, shares in Everest Organics are trading at IN₹318.95. This share price information is delayed by 15 minutes.
How has the Everest Organics share price performed this year?
Shares in Everest Organics last closed at IN₹318.95 and the price had moved by +143.94% over the past 365 days. In terms of relative price strength the Everest Organics share price has outperformed the S&P BSE 100 Index by +129.79% over the past year.
What are the analyst and broker recommendations for Everest Organics?
There is no consensus recommendation for this security.
Find out moreWhat is the Everest Organics dividend yield?
Everest Organics does not currently pay a dividend.
Does Everest Organics pay a dividend?
Everest Organics does not currently pay a dividend.
When does Everest Organics next pay dividends?
Everest Organics does not currently pay a dividend.
How do I buy Everest Organics shares?
To buy shares in Everest Organics you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Everest Organics?
As of the previous close price of IN₹318.95, shares in Everest Organics had a market capitalisation of IN₹3.41bn.
Where are Everest Organics shares listed?
Here are the trading details for Everest Organics:
- Country of listing: India
- Exchange: BSE
- Ticker Symbol: 524790
What kind of share is Everest Organics?
Based on an overall assessment of its quality, value and momentum Everest Organics is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Everest Organics share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Everest Organics share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Everest Organics. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +162.77%.
As of the last closing price of IN₹318.95, shares in Everest Organics were trading +62.04% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Everest Organics PE Ratio?
The Everest Organics PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at IN₹318.95.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Everest Organics?
Everest Organics' management team is headed by:
- Srikakarlapudi Sirisha - CEO
- Rekha Singh - CCO
- Sri Raju - MDR
- M. Bangara Raju - EDR
- S.K.Hari Krishna - EDR
- A. Parvatisem - EDR
- G. Sreeramakrishna - DRC
- Raju Kakarlapudi - NED
- Venkatasatyanarayana Chayaly - NID
- Sreeramakrishna Grandhi - NID
- K. Rama Raju - NID